To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers | MicrobiomeTrials← Back to trialsNCT03651349
To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2021-02-01Est. Completion: 2027-12-31
Enrollment target: 56 participants Locations- Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien City, Taiwan
Other microbiome trials you might be interested in
Healthy
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (i.e. how study drug is taken up by…
Multiple LocationsEst. completion Mar 31, 2029
Amyotrophic Lateral Sclerosis (ALS)Mutation in the Superoxide Dismutase-1 (SOD1) Gene
This study is researching an experimental drug called ALN-SOD (called "study drug"). This study is focused on people wit…
Concord, AustraliaEst. completion Mar 21, 2032